{"id":19330,"date":"2016-02-23T13:31:28","date_gmt":"2016-02-23T12:31:28","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=19330"},"modified":"2016-02-23T13:31:28","modified_gmt":"2016-02-23T12:31:28","slug":"taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","title":{"rendered":"Taller de comparaciones indirectas y metan\u00e1lisis en red"},"content":{"rendered":"<figure id=\"attachment_19386\" aria-describedby=\"caption-attachment-19386\" style=\"width: 367px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/comparacions-indirectes-metaanalisi-xarxa-4.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-19386\" alt=\"comparacions-indirectes-metaanalisi-xarxa (4)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/comparacions-indirectes-metaanalisi-xarxa-4.jpg\" width=\"367\" height=\"210\" \/><\/a><figcaption id=\"caption-attachment-19386\" class=\"wp-caption-text\">Aurelio Tob\u00edas, docente del curso, durante su intervenci\u00f3n<\/figcaption><\/figure>\n<p>\u201cCada a\u00f1o se comercializan nuevos principios activos y nuevos medicamentos por indicaciones en las que ya tenemos diferentes tratamientos establecidos. Las agencias reguladoras, tanto a nivel americano como a nivel europeo, s\u00f3lo requieren a la industria farmac\u00e9utica que el nuevo medicamento haya demostrado eficacia y seguridad frente a placebo para dar la autorizaci\u00f3n a su comercializaci\u00f3n. No es necesario que el nuevo medicamento, por estar disponible en el mercado, haya demostrado no inferioridad o superioridad en comparaci\u00f3n con los tratamientos ya comercializados con su misma indicaci\u00f3n o por la misma patolog\u00eda\u201d explica <strong>Roser Vall\u00e8s, vocal de Atenci\u00f3n Primaria del COFB<\/strong>: \u201cEsto implica que <b>el profesional sanitario<\/b>, cuando debe valorar si el nuevo medicamento le aporta alguna ventaja frente a los tratamientos ya conocidos o cuando quiere establecer el sitio en terap\u00e9utica de esta novedad, <b>muchas veces no dispone de estudios comparativos directos (ensayos cl\u00ednicos, metan\u00e1lisis) que le permitan establecer correctamente qu\u00e9 ventajas o desventajas le puede aportar este nuevo medicamento\u201d.<\/b><\/p>\n<figure id=\"attachment_19385\" aria-describedby=\"caption-attachment-19385\" style=\"width: 306px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/comparacions-indirectes-metaanalisi-xarxa-3.jpg\"><img decoding=\"async\" class=\"wp-image-19385\" alt=\"comparacions-indirectes-metaanalisi-xarxa (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/comparacions-indirectes-metaanalisi-xarxa-3.jpg\" width=\"306\" height=\"204\" \/><\/a><figcaption id=\"caption-attachment-19385\" class=\"wp-caption-text\">Roser Vall\u00e8s, vocal de Atenci\u00f3n Primaria del COFB, y una de las coordinadoras de la formaci\u00f3n<\/figcaption><\/figure>\n<p>\u201cPara intentar paliar esta falta de evidencia cient\u00edfica en los \u00faltimos a\u00f1os se est\u00e1n publicando muchos estudios de metan\u00e1lisis indirectos y m\u00e1s recientemente los metan\u00e1lisis en red para intentar establecer comparaciones entre diferentes f\u00e1rmacos que no disponen de comparaciones directas entre s\u00ed\u201d matiza Vall\u00e8s . El <b>Taller de comparaciones indirectas y metan\u00e1lisis en red,<\/b> que acogi\u00f3 el COFB el pasado 4 de febrero, permiti\u00f3 a los asistentes introducir estos conceptos y tambi\u00e9n los principales modelos de consistencia e inconsistencia para el an\u00e1lisis estad\u00edstico de un metan\u00e1lisis en red. La formaci\u00f3n corri\u00f3 a cargo de<b>Aurelio Tob\u00edas<\/b>, doctor en medicina preventiva y salud p\u00fablica, licenciado en ciencias y t\u00e9cnica estad\u00edstica y diplomado en estad\u00edstica, investigador cient\u00edfico del Consejo Superior de Investigaciones Cient\u00edficas (CSIC) en el Instituto de Diagn\u00f3stico Ambiental y Estudios del Agua en Barcelona, e investigador visitante en la London School of Hygiene and Tropical Medicine en Londres.<\/p>\n<p>\u201cLos conceptos b\u00e1sicos de c\u00f3mo se hacen estas comparaciones y metan\u00e1lisis son muy \u00fatiles para los farmac\u00e9uticos cl\u00ednicos porque<b> nos ayudan a saber interpretar mejor los resultados de estos estudios y establecer su relevancia dentro del an\u00e1lisis global que hacemos del sitio en terap\u00e9utica de las novedades terap\u00e9uticas que constantemente est\u00e1n apareciendo en el mercado en las condiciones anteriormente descritas<\/b>\u201d explica Vall\u00e8s, una de las coordinadoras de la formaci\u00f3n, junto con Esther Amado, vocal en Catalu\u00f1a de la Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria (SEFAP), Tom\u00e0s Casas\u00edn, vocal de Hospitales del COFB, y Julio Mart\u00ednez, presidente de la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC).<\/p>\n<div class=\"box shadow\">En el contexto de una revisi\u00f3n sistem\u00e1tica, un metan\u00e1lisis en red es una extensi\u00f3n del metan\u00e1lisis cl\u00e1sico de comparaciones directas en las que en lugar de realizar un metan\u00e1lisis por separado de varios estudios para el tratamiento A con relaci\u00f3n al comparador B (A comparado con B) o para el tratamiento C respecto al comparador B (C comparado con B), se hace una valoraci\u00f3n de la red completa , C comparado con B y B comparado con A).<\/div>\n<p><span style=\"color: #888888;\"><b>Actividad organizada conjuntamente con la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC) y la Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria (SEFAP).<\/b><b>\u00a0<\/b><\/span><\/p>\n<p align=\"right\"><b>Con la colaboraci\u00f3n de:<\/b><\/p>\n<p align=\"right\"><b><a href=\"http:\/\/www.astellas.es\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignright size-thumbnail wp-image-19331\" alt=\"astellas-logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/astellas-logo-150x62.jpg\" width=\"150\" height=\"62\" \/><\/a> <\/b><\/p>\n<p align=\"right\">","protected":false},"excerpt":{"rendered":"<p>\u201cCada a\u00f1o se comercializan nuevos principios activos y nuevos medicamentos por indicaciones en las que ya tenemos diferentes tratamientos establecidos. Las agencias reguladoras, tanto a nivel americano como a nivel europeo, s\u00f3lo requieren a la industria farmac\u00e9utica que el nuevo medicamento haya demostrado eficacia y seguridad frente a placebo para dar la autorizaci\u00f3n a [\u2026]<\/p>","protected":false},"author":1,"featured_media":19386,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[938,2322,2323,480,2324],"class_list":["post-19330","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-primaria","tag-comparacions-indirectes","tag-farmacia-clinica","tag-farmacia-hospitalaria","tag-metanalisi-en-xarxa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u201cCada any es comercialitzen nous principis actius i nous medicaments per indicacions on ja tenim diferents tractaments establerts. Les ag\u00e8ncies reguladores, tant a nivell americ\u00e0 com a nivell europeu, nom\u00e9s requereixen a la ind\u00fastria farmac\u00e8utica que el nou medicament hagi demostrat efic\u00e0cia i seguretat enfront placebo per donar l\u2019autoritzaci\u00f3 a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-23T12:31:28+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Taller de comparacions indirectes i metan\u00e0lisi en xarxa\",\"datePublished\":\"2016-02-23T12:31:28+00:00\",\"dateModified\":\"2016-02-23T12:31:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\"},\"wordCount\":655,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 prim\u00e0ria\",\"comparacions indirectes\",\"farm\u00e0cia cl\u00ednica\",\"farm\u00e0cia hospital\u00e0ria\",\"metan\u00e0lisi en xarxa\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\",\"name\":\"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-02-23T12:31:28+00:00\",\"dateModified\":\"2016-02-23T12:31:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Taller de comparacions indirectes i metan\u00e0lisi en xarxa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","og_locale":"es_ES","og_type":"article","og_title":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u201cCada any es comercialitzen nous principis actius i nous medicaments per indicacions on ja tenim diferents tractaments establerts. Les ag\u00e8ncies reguladores, tant a nivell americ\u00e0 com a nivell europeu, nom\u00e9s requereixen a la ind\u00fastria farmac\u00e8utica que el nou medicament hagi demostrat efic\u00e0cia i seguretat enfront placebo per donar l\u2019autoritzaci\u00f3 a [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-02-23T12:31:28+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa","datePublished":"2016-02-23T12:31:28+00:00","dateModified":"2016-02-23T12:31:28+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/"},"wordCount":655,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 prim\u00e0ria","comparacions indirectes","farm\u00e0cia cl\u00ednica","farm\u00e0cia hospital\u00e0ria","metan\u00e0lisi en xarxa"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","url":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","name":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-02-23T12:31:28+00:00","dateModified":"2016-02-23T12:31:28+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u201cCada any es comercialitzen nous principis actius i nous medicaments per indicacions on ja tenim diferents tractaments establerts. Les ag\u00e8ncies reguladores, tant a nivell americ\u00e0 com a nivell europeu, nom\u00e9s requereixen a la ind\u00fastria farmac\u00e8utica que el nou medicament hagi demostrat efic\u00e0cia i seguretat enfront placebo per donar l\u2019autoritzaci\u00f3 a [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/19330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=19330"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/19330\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=19330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=19330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=19330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}